Skip to main content
Dementia and Neurocognitive Disorders logoLink to Dementia and Neurocognitive Disorders
. 2023 Apr 6;22(2):84. doi: 10.12779/dnd.2023.22.2.84

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure

YoungSoon Yang 1, Vo Van Giau 2, Seong Soo A An 2, SangYun Kim 3
PMCID: PMC10166677  PMID: 37179690

Dement Neurocogn Disord. 2018;17(2):41-49 / https://doi.org/10.12779/dnd.2018.17.2.41

Unfortunately, the original version of this article contained an error in Table 1.

Table 1 shows basic demographic characteristics of the AD patient group with Agent Orange exposure (n = 48), without Agent Orange (n = 66), and the group of participants without AD (n = 60). In this table, values of apolipoprotein E ε4 genetic variance (homozygote or heterozygote) 38 (57.5%) and 27 (56.2%) were swapped with each other. There was no statistically significant difference. Likewise, 38 (57.5%) and 27 (56.2%) in Table 1 should be changed to 27 (56.2%) and 38 (57.5%).

The correct table is shown below (revised values indicated bold-face font):

Table 1. Baseline characteristics

graphic file with name dnd-22-84-g001.jpg

AD: Alzheimer’s disease, AO: Agent Orange exposure, NC: normal controls, MMSE: Mini-Mental State Examination.


Articles from Dementia and Neurocognitive Disorders are provided here courtesy of Korean Dementia Association

RESOURCES